- Home
- TKNO vs BNTC Comparison
TKNO vs BNTC Comparison
Compare TKNO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKNO
- BNTC
- Stock Information
- Founded
- TKNO 1996
- BNTC 1995
- Country
- TKNO United States
- BNTC United States
- Employees
- TKNO N/A
- BNTC N/A
- Industry
- TKNO Medicinal Chemicals and Botanical Products
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- TKNO Health Care
- BNTC Health Care
- Exchange
- TKNO Nasdaq
- BNTC Nasdaq
- Market Cap
- TKNO 356.4M
- BNTC 366.6M
- IPO Year
- TKNO 2021
- BNTC N/A
- Fundamental
- Price
- TKNO $4.49
- BNTC $12.85
- Analyst Decision
- TKNO Buy
- BNTC Strong Buy
- Analyst Count
- TKNO 1
- BNTC 6
- Target Price
- TKNO $5.00
- BNTC $23.83
- AVG Volume (30 Days)
- TKNO 310.6K
- BNTC 237.2K
- Earning Date
- TKNO 08-12-2025
- BNTC 05-14-2025
- Dividend Yield
- TKNO N/A
- BNTC N/A
- EPS Growth
- TKNO N/A
- BNTC N/A
- EPS
- TKNO N/A
- BNTC N/A
- Revenue
- TKNO $38,250,000.00
- BNTC N/A
- Revenue This Year
- TKNO $8.73
- BNTC N/A
- Revenue Next Year
- TKNO $16.53
- BNTC N/A
- P/E Ratio
- TKNO N/A
- BNTC N/A
- Revenue Growth
- TKNO 3.79
- BNTC N/A
- 52 Week Low
- TKNO $1.23
- BNTC $7.05
- 52 Week High
- TKNO $10.37
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- TKNO 30.32
- BNTC 50.13
- Support Level
- TKNO $4.90
- BNTC $12.57
- Resistance Level
- TKNO $5.38
- BNTC $13.88
- Average True Range (ATR)
- TKNO 0.33
- BNTC 1.18
- MACD
- TKNO -0.02
- BNTC 0.02
- Stochastic Oscillator
- TKNO 3.41
- BNTC 62.63
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.